what dose is a microdose of semaglutide GLP-1 Microdosing Chart: Tirzepatide and Gen Z Is Leading a

It's not what you crave

This multi-agent approach, increasingly supported by dermatology literature, is only possible through compounding

Semaglutide is a glucagon-like peptide (GLP)-1 receptor agonist primarily used in type 2 diabetes treatment and has also increased in use as a weight loss drug

Comprehensive Metabolic Support By attacking weight gain from both a metabolic and a neurological perspective, this combination addresses the complexity of obesity

Reach out to friends, family, or a support group where you can share your experiences and feelings

Among patients with type 2 diabetes, GLP-1 use was associated with a 32% lower risk of fracture for those with osteopenia and for those with osteoporosis, as seen in Figure 1